Exane Derivatives’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $865 | Hold |
48
| – | – | ﹤0.01% | 520 |
|
|
2022
Q1 | $1.28K | Hold |
48
| – | – | ﹤0.01% | 781 |
|
|
2021
Q4 | $1.41K | Hold |
48
| – | – | ﹤0.01% | 672 |
|
|
2021
Q3 | $3.16K | Hold |
48
| – | – | ﹤0.01% | 748 |
|
|
2021
Q2 | $4.01K | Sell |
48
-785
| -94% | -$65.5K | ﹤0.01% | 769 |
|
|
2021
Q1 | $63.9K | Sell |
833
-1,037
| -55% | -$79.5K | 0.02% | 483 |
|
|
2020
Q4 | $165K | Hold |
1,870
| – | – | 0.05% | 328 |
|
|
2020
Q3 | $138K | Sell |
1,870
-82
| -4% | -$6.05K | 0.04% | 232 |
|
|
2020
Q2 | $142K | Buy |
1,952
+322
| +20% | +$23.5K | 0.04% | 224 |
|
|
2020
Q1 | $91.5K | Buy |
+1,630
| New | +$91.5K | 0.03% | 273 |
|